Access In Jeopardy If Generics Excluded From EU Centralized Procedure
Industry Body Urges European Commission’s Pharmaceutical Committee To Abandon Idea
Executive Summary
Recent suggestions by the European Commission’s Pharmaceutical Committee that generics could be excluded from the centralized procedure for marketing authorizations would create barriers to access and put extra pressure on the European regulatory network overall, Medicines for Europe believes. The association has urged the authorities to abandon the idea.